Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Villeirs

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)|July 25, 2020
How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1Ana Sofia Linhares Moreira, Pieter De Visschere, Charles Van Praet, et al.
Journal of the Belgian Society of Radiology|July 25, 2018
Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and 2 in a Cohort of 245 Patients with Histopathological Reference and Long-Term Follow-UpPieter De Visschere, Eva Pattyn, Piet Ost, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2004
Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancerGert De Meerleer, Luc Vakaet, Werner De Gersem, et al.
European Radiology|June 8, 2019
The primacy of multiparametric MRI in men with suspected prostate cancerJonathan Richenberg, Vibeke Løgager, Valeria Panebianco, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2007
Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicityValérie Fonteyne, Wilfried De Neve, Geert Villeirs, et al.
Cancers|November 14, 2023
Risk Biomarkers for Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer Using Clinical and MRI-Derived Semantic FeaturesAdalgisa Guerra, Filipe Caseiro Alves, Kris Maes, et al.
European Urology|June 9, 2009
Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patientsPiet Ost, Valérie Fonteyne, Geert Villeirs, et al.
Clinical Imaging|March 5, 2015
Prostate magnetic resonance spectroscopic imaging at 1.5tesla with endorectal coil versus 3.0tesla without endorectal coil: comparison of spectral qualityPieter De Visschere, Marco Nezzo, Eva Pattyn, et al.
Urology|May 28, 2013
Developments in external beam radiotherapy for prostate cancerNicolaas Lumen, Piet Ost, Charles Van Praet, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 7, 2018
Feasibility study using iodine quantification on dual-energy CT enterography to distinguish normal small bowel from active inflammatory Crohn's diseaseIsabelle De Kock, Louke Delrue, Clarisse Lecluyse, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Acta Radiologica (Stockholm, Sweden : 1987)|July 25, 2020
How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1Ana Sofia Linhares Moreira, Pieter De Visschere, Charles Van Praet, et al.
Journal of the Belgian Society of Radiology|July 25, 2018
Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and 2 in a Cohort of 245 Patients with Histopathological Reference and Long-Term Follow-UpPieter De Visschere, Eva Pattyn, Piet Ost, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2004
Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancerGert De Meerleer, Luc Vakaet, Werner De Gersem, et al.
European Radiology|June 8, 2019
The primacy of multiparametric MRI in men with suspected prostate cancerJonathan Richenberg, Vibeke Løgager, Valeria Panebianco, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2007
Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicityValérie Fonteyne, Wilfried De Neve, Geert Villeirs, et al.
Cancers|November 14, 2023
Risk Biomarkers for Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer Using Clinical and MRI-Derived Semantic FeaturesAdalgisa Guerra, Filipe Caseiro Alves, Kris Maes, et al.
European Urology|June 9, 2009
Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patientsPiet Ost, Valérie Fonteyne, Geert Villeirs, et al.
Clinical Imaging|March 5, 2015
Prostate magnetic resonance spectroscopic imaging at 1.5tesla with endorectal coil versus 3.0tesla without endorectal coil: comparison of spectral qualityPieter De Visschere, Marco Nezzo, Eva Pattyn, et al.
Urology|May 28, 2013
Developments in external beam radiotherapy for prostate cancerNicolaas Lumen, Piet Ost, Charles Van Praet, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 7, 2018
Feasibility study using iodine quantification on dual-energy CT enterography to distinguish normal small bowel from active inflammatory Crohn's diseaseIsabelle De Kock, Louke Delrue, Clarisse Lecluyse, et al.
Pageof 10